Mackenzie Financial’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-3,000
| Closed | -$261K | – | 1134 |
|
|
2019
Q3 | $261K | Buy |
+3,000
| New | +$269K | ﹤0.01% | 915 |
|
|
2019
Q2 | – | Sell |
-2,790
| Closed | -$211K | – | 1208 |
|
|
2019
Q1 | $211K | Buy |
+2,790
| New | +$224K | ﹤0.01% | 1164 |
|
|
2018
Q3 | – | Sell |
-33,917
| Closed | -$2.3M | – | 1138 |
|
|
2018
Q2 | $2.3M | Hold |
33,917
| – | – | 0.01% | 578 |
|
|
2018
Q1 | $2.46M | Buy |
33,917
+24,785
| +271% | +$1.89M | 0.01% | 538 |
|
|
2017
Q4 | $687K | Buy |
9,132
+2,154
| +31% | +$163K | ﹤0.01% | 647 |
|
|
2017
Q3 | $537K | Sell |
6,978
-13
| -0.2% | -$982 | ﹤0.01% | 512 |
|
|
2017
Q2 | $523K | Buy |
+6,991
| New | +$495K | ﹤0.01% | 514 |
|
|
2016
Q3 | – | Sell |
-119,043
| Closed | -$8.8M | – | 805 |
|
|
2016
Q2 | $8.8M | Buy |
119,043
+1,340
| +1% | +$92.6K | 0.05% | 264 |
|
|
2016
Q1 | $7.64M | Buy |
117,703
+54,164
| +85% | +$3.68M | 0.07% | 227 |
|
|
2015
Q4 | $4.9M | Buy |
63,539
+2,551
| +4% | +$203K | 0.03% | 313 |
|
|
2015
Q3 | $5.02M | Hold |
60,988
| – | – | 0.03% | 291 |
|
|
2015
Q2 | $5.37M | Sell |
60,988
-2,880
| -5% | -$264K | 0.03% | 301 |
|
|
2015
Q1 | $5.64M | Sell |
63,868
-6,561
| -9% | -$582K | 0.03% | 307 |
|
|
2014
Q4 | $5.85M | Buy |
70,429
+1,697
| +2% | +$141K | 0.03% | 305 |
|
|
2014
Q3 | $5.8M | Buy |
68,732
+1,809
| +3% | +$146K | 0.03% | 305 |
|
|
2014
Q2 | $5.43M | Buy |
66,923
+11,116
| +20% | +$874K | 0.03% | 323 |
|
|
2014
Q1 | $4.25M | Buy |
55,807
+8,013
| +17% | +$584K | 0.02% | 333 |
|
|
2013
Q4 | $3.44M | Sell |
47,794
-1,759
| -4% | -$122K | 0.02% | 335 |
|
|
2013
Q3 | $3.41M | Buy |
49,553
+1,113
| +2% | +$73.6K | 0.02% | 331 |
|
|
2013
Q2 | $3.07M | Buy |
+48,440
| New | +$3.15M | 0.01% | 351 |
|
Other funds holding NVS
